Community-Acquired Pneumonia | Feasibility and Outcomes of Older Patients Hospitalization
Community-Acquired Pneumonia research study
What is the primary objective of this study?
Hospitalization is a traumatic event for the patient and his family at any age nevertheless in the older age. One of its consequences is the difficulty to resume previous activity of daily living especially in older (over 75 years) patients. Sub acute completes the acute phase of the hospitalization and its main purpose is to improve the patient's functional status and quality of life. There are not enough clinical trails to proof this assumption. The purpose of our study is to compare the outcome of acute and sub-acute hospitalization programs by a randomized controlled prospective intervention study. Outcome measures will comprise activity of daily living, functional status, re-hospitalization and utilization of medical services following the hospitalization.Study hypothesis is that sub-acute hospitalization will improve outcomes and will cost less.
Who is eligible to participate?
Inclusion Criteria: - Age over 65 - Hemodynamic, nutritional and respiratory stability - eligibility for sub- acute hospitalization Exclusion Criteria: - Oncological active disease - uncorrectable hypoxemia (oxygen saturation 90%), - suspected myocardial ischemia - presence of an acute illness, other than the target illness
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Exacerbation of Chronic Heart Failure
Exacerbation of Chronic Obstructive Pulmonary Disease
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: July 2007
Completed Date: August 2007
Study sponsors, principal investigator, and references
Principal Investigator: Doron Nezer, M.D.
Lead Sponsor: Hillel Yaffe Medical Center